<DOC>
	<DOCNO>NCT00105287</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability OraVescent fentanyl use long-term relieve breakthrough pain opioid tolerant cancer patient .</brief_summary>
	<brief_title>Treatment Breakthrough Pain Opioid Tolerant Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Breakthrough Pain</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<criteria>Documented diagnosis malignant solid tumor hematological malignancy cause cancer relate pain Currently take around clock opioid therapy pain Experience average , 14 breakthrough pain episode per day Opioid fentanyl intolerance Sleep apnea active brain metastasis increase intracranial pressure COPD ( chronic obstructive pulmonary disease ) ; cardiopulmonary disease ; heart disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>cancer</keyword>
	<keyword>pain</keyword>
	<keyword>Breakthrough Pain cancer patient</keyword>
</DOC>